Calcium Hydroxylapatite‐Carboxymethylcellulose as a Treatment for Forearm Dermatoporosis: A Prospective, Delayed‐Start, Contralateral Case Series

Key Points

• To evaluate the effectiveness of hyperdiluted calcium hydroxylapatite-carboxymethylcellulose in treating forearm dermatoporosis.
• Conducted a prospective, delayed-start, contralateral case series
• Administered a single session of hyperdiluted CaHA-CMC
• Assessed outcomes using clinical evaluations, histologic examinations, and ultrasonographic measurements.
• Achieved rapid clinical improvement in dermatoporosis symptoms
• Showed durable histologic enhancements
• Confirmed ultrasonographic improvements in treated areas.

Abstract